← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2009Last known activity
Jun 28, 2025
Timeline
2000s
- Jun 1, 2001
Beike Biotech— Founded
2010s
- Jun 1, 2015
Abingen Ltd— Acquired
Drugs by trial phase (6 distinct, 11 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Indications
Studied for
- Ataxia
- Autistic Disorder
- Burns
- Cerebellar Ataxia
- Diabetic Foot
- Fibrosis
- Ischemia
- Leg Ulcer
- Liver Cirrhosis
- Lupus Nephritis
- Menopause, Premature
- Multiple Sclerosis
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Nephritis
- Neuromyelitis Optica
- Premature Birth
- Primary Ovarian Insufficiency
- Sclerosis
- Spinocerebellar Degenerations
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (11)
- NCT07041801Lead sponsorPhase 1/Phase 2Jun 28, 2025
- NCT01742533Lead sponsorPhase 1/Phase 2Mar 1, 2012
- NCT01539902Lead sponsorPhase 2Feb 1, 2012
- NCT01610440Lead sponsorPhase 1/Phase 2Oct 1, 2011
- NCT01443689Lead sponsorPhase 1/Phase 2Jul 1, 2011
- NCT01342250Lead sponsorPhase 1/Phase 2Oct 1, 2010
- NCT01364246Lead sponsorPhase 1/Phase 2Jan 1, 2010
- NCT01360164Lead sponsorPhase 1/Phase 2Jan 1, 2010
- NCT00922389Study directorPhase 1/Phase 2Jul 1, 2009
- NCT00922389Lead sponsorPhase 1/Phase 2Jul 1, 2009
- NCT01343511Lead sponsorPhase 1/Phase 2Mar 1, 2009
Details
- Founded
- Shenzhen, CN Jun 1, 2001
- Last known activity
- Jun 28, 2025
Notes
NO NEWS SINCE 2017